BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17490628)

  • 1. Expression of high levels of human proteinase inhibitor 9 blocks both perforin/granzyme and Fas/Fas ligand-mediated cytotoxicity.
    Cunningham TD; Jiang X; Shapiro DJ
    Cell Immunol; 2007 Jan; 245(1):32-41. PubMed ID: 17490628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway.
    Vermijlen D; Luo D; Froelich CJ; Medema JP; Kummer JA; Willems E; Braet F; Wisse E
    J Leukoc Biol; 2002 Oct; 72(4):668-76. PubMed ID: 12377935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly inhibits activities of natural killer cells, cytotoxic T lymphocytes and lymphokine-activated killer cells via the Fas-ligand/Fas pathway in perforin-knockout (PKO) mice.
    Li Q; Nakadai A; Takeda K; Kawada T
    Toxicology; 2004 Nov; 204(1):41-50. PubMed ID: 15369847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells.
    Oshimi Y; Oda S; Honda Y; Nagata S; Miyazaki S
    J Immunol; 1996 Oct; 157(7):2909-15. PubMed ID: 8816396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas-mediated cytotoxicity remains intact in perforin and granzyme B antisense transfectants of a human NK-like cell line.
    Montel AH; Bochan MR; Goebel WS; Brahmi Z
    Cell Immunol; 1995 Oct; 165(2):312-7. PubMed ID: 7553897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CPP32-like proteases prevents granzyme B- and Fas-, but not granzyme A-based cytotoxicity exerted by CTL clones.
    Anel A; Gamen S; Alava MA; Schmitt-Verhulst AM; Piñeiro A; Naval J
    J Immunol; 1997 Mar; 158(5):1999-2006. PubMed ID: 9036942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Fas-ligand expression on porcine endothelial cells does not protect against xenogeneic natural killer cytotoxicity.
    Matter-Reissmann UB; Sonntag KC; Gilli UO; Leguern C; Schneider MK; Seebach JD
    Xenotransplantation; 2004 Jan; 11(1):43-52. PubMed ID: 14962292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFNalpha2b stimulated release of IFNgamma differentially regulates T cell and NK cell mediated tumor cell cytotoxicity.
    Bose A; Baral R
    Immunol Lett; 2007 Jan; 108(1):68-77. PubMed ID: 17112599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of Fas ligand in cytoplasmic granules of CD8+ cytotoxic T lymphocytes and natural killer cells: participation of Fas ligand in granule exocytosis model of cytotoxicity.
    Kojima Y; Kawasaki-Koyanagi A; Sueyoshi N; Kanai A; Yagita H; Okumura K
    Biochem Biophys Res Commun; 2002 Aug; 296(2):328-36. PubMed ID: 12163021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2 prevents apoptosis induced by perforin and granzyme B, but not that mediated by whole cytotoxic lymphocytes.
    Sutton VR; Vaux DL; Trapani JA
    J Immunol; 1997 Jun; 158(12):5783-90. PubMed ID: 9190929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity.
    Mitsui T; Miyake Y; Kakeya H; Osada H; Kataoka T
    J Immunol; 2004 Mar; 172(6):3428-36. PubMed ID: 15004142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
    J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.
    Lee SH; Bar-Haim E; Machlenkin A; Goldberger O; Volovitz I; Vadai E; Tzehoval E; Eisenbach L
    Cancer Gene Ther; 2004 Mar; 11(3):237-48. PubMed ID: 14739939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiestrogens affect both pathways of killer cell-mediated oncolysis.
    Haeryfar SM; Nagy E; Baral E; Krepart G; Lotocki R; Berczi I
    Anticancer Res; 2000; 20(3A):1849-53. PubMed ID: 10928117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.
    Yu Y; Hagihara M; Ando K; Gansuvd B; Matsuzawa H; Tsuchiya T; Ueda Y; Inoue H; Hotta T; Kato S
    J Immunol; 2001 Feb; 166(3):1590-600. PubMed ID: 11160200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New mechanism of organophosphorus pesticide-induced immunotoxicity.
    Li Q
    J Nippon Med Sch; 2007 Apr; 74(2):92-105. PubMed ID: 17507786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.
    Liu AN; Mohammed AZ; Rice WR; Fiedeldey DT; Liebermann JS; Whitsett JA; Braciale TJ; Enelow RI
    Am J Respir Cell Mol Biol; 1999 May; 20(5):849-58. PubMed ID: 10226053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent.
    Mori S; Jewett A; Murakami-Mori K; Cavalcanti M; Bonavida B
    Cancer Immunol Immunother; 1997 Jul; 44(5):282-90. PubMed ID: 9247563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas Ligand localizes to intraluminal vesicles within NK cell cytolytic granules and is enriched at the immune synapse.
    Lee J; Dieckmann NMG; Edgar JR; Griffiths GM; Siegel RM
    Immun Inflamm Dis; 2018 Jun; 6(2):312-321. PubMed ID: 29642281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytolytic capabilities of lamina propria and intraepithelial lymphocytes in normal and chronically inflamed human intestine.
    Melgar S; Hammarström S; Oberg A; Danielsson A; Hammarström ML
    Scand J Immunol; 2004; 60(1-2):167-77. PubMed ID: 15238086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.